Scarica l'app Stockscreener
75.20
0.01%
0.01
Pre-mercato:
75.11
-0.09
-0.12%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$75.19
Aprire:
$75.14
Volume 24 ore:
4.52M
Relative Volume:
1.46
Capitalizzazione di mercato:
$16.79B
Reddito:
$4.04B
Utile/perdita netta:
$557.10M
Rapporto P/E:
31.20
EPS:
2.4102
Flusso di cassa netto:
$916.70M
1 W Prestazione:
+0.12%
1M Prestazione:
+0.94%
6M Prestazione:
+13.08%
1 anno Prestazione:
+3.37%
Intervallo 1D:
$72.28
$75.36
Intervallo di 1 settimana:
$72.28
$75.36
Portata 52W:
$51.90
$75.36
Hologic Inc Stock (HOLX) Company Profile
Nome
Hologic Inc
Settore
Industria
Telefono
(508) 263-2900
Indirizzo
250 CAMPUS DRIVE, MARLBOROUGH, MA
Confronta HOLX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
75.20 | 16.79B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
525.04 | 187.46B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
203.40 | 57.96B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.87 | 39.68B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
46.31 | 37.32B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
255.50 | 37.29B | 5.26B | 1.44B | 1.76B | 9.7713 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-12 | Downgrade | Argus | Buy → Hold |
| 2026-01-05 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-11-21 | Downgrade | BNP Paribas Exane | Outperform → Neutral |
| 2025-10-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-08-18 | Aggiornamento | Argus | Hold → Buy |
| 2025-08-06 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-07-09 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-05-27 | Reiterato | Needham | Hold |
| 2025-03-03 | Downgrade | Argus | Buy → Hold |
| 2025-02-06 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | Downgrade | Needham | Buy → Hold |
| 2024-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2024-12-10 | Iniziato | Jefferies | Hold |
| 2024-12-10 | Reiterato | Needham | Buy |
| 2024-10-01 | Downgrade | Citigroup | Buy → Neutral |
| 2024-06-27 | Iniziato | Stephens | Overweight |
| 2024-04-03 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-07-14 | Aggiornamento | Needham | Hold → Buy |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | Iniziato | Mizuho | Buy |
| 2022-07-20 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-07-20 | Iniziato | UBS | Neutral |
| 2022-07-18 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2021-12-15 | Downgrade | Citigroup | Buy → Neutral |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-10-14 | Iniziato | Redburn | Neutral |
| 2021-07-06 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2020-11-20 | Downgrade | Needham | Buy → Hold |
| 2020-11-05 | Reiterato | Needham | Buy |
| 2020-06-30 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2020-06-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | Reiterato | Needham | Buy |
| 2020-04-30 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | Reiterato | Needham | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Equal Weight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | Reiterato | Needham | Buy |
| 2019-05-02 | Reiterato | Needham | Buy |
| 2019-01-31 | Reiterato | Needham | Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | Iniziato | UBS | Neutral |
| 2018-09-13 | Downgrade | BofA/Merrill | Buy → Neutral |
Mostra tutto
Hologic Inc Borsa (HOLX) Ultime notizie
Why Analysts Are Rethinking The Story Behind Hologic (HOLX) After New Price Targets - Yahoo Finance
Hologic (HOLX) Q4 Earnings: What To Expect - Finviz
HOLOGIC Q1 2026 Earnings Preview: Recent $HOLX Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
Assessing Hologic (HOLX) Valuation As Shares Hover Near Analyst Fair Value Estimates - Yahoo Finance
Hologic stock hits 52-week high at 75.34 USD - Investing.com
Hologic Faces Merger-Related Stockholder Suits, Issues Disclosures - TipRanks
Stay Ahead of the Game With Hologic (HOLX) Q1 Earnings: Wall Street's Insights on Key Metrics - Yahoo Finance
The Truth About Hologic Inc: Why This ‘Boring’ Stock Could Be a Silent Game-Changer - AD HOC NEWS
Universal Beteiligungs und Servicegesellschaft mbH Raises Holdings in Hologic, Inc. $HOLX - MarketBeat
Hologic Faces Del. Class Suit Over $18.3B Sale Disclosures - Law360
Anatomic Pathology Market Research: Global and Regional Insights, Competition, Forecast and Opportunities, 2025-2033 | Astute Analytica - GlobeNewswire Inc.
Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Finviz
Hologic Q1 Earnings Preview: How Should You Play the Stock Now? - Finviz
Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report? - Finviz
Here's Why Hologic (HOLX) is a Strong Momentum Stock - Yahoo Finance
Will GYN Surgical Power Hologic's Growth in the Upcoming Q1 Earnings? - The Globe and Mail
(HOLX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Hologic, Inc. (HOLX): A Bear Case Theory - Finviz
Hologic, Inc. (HOLX): A bear case theory - MSN
Aug Shorts: Is Hologic Inc attractive for institutional investors2025 Key Highlights & Advanced Technical Analysis Signals - baoquankhu1.vn
HOLX vs. SYK: Which Medical Device Leader Is a Solid Bet Now? - Nasdaq
3D Imaging Teleradiology Service Market Hits New High | Major - openPR.com
Is Hologic Inc. stock a buy or sellJuly 2025 Trends & Long-Term Growth Stock Strategies - bollywoodhelpline.com
Is It Time To Reassess Hologic (HOLX) After Recent Valuation Signals - Yahoo Finance
Hologic says 2026 CVR is more challenging with stopped shipment of product - MSN
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It - sharewise.com
'Good Morning Gorgeous': Hologic, Mary J. Blige Team To Tout Well Woman Exams 08/22/2022 - MediaPost
How low can spreads go? Hologic’s mega LBO tests the limit - PitchBook
Hologic wraps massive syndicated LBO loan - PitchBook
Hologic Leads Campaign to Emphasize Routine Cervical Cancer Screening - The Globe and Mail
61,780 Shares in Hologic, Inc. $HOLX Purchased by Campbell & CO Investment Adviser LLC - MarketBeat
Press Release: Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026 - 富途资讯
As Blackstone and TPG pursue Hologic deal, Q1 results arrive Jan. 29 - Stock Titan
Hologic to Announce Financial Results for the First Quarter of Fiscal 2026 on Thursday, January 29, 2026 - Hologic
About Us - FinancialContent
Hologic’s $8.5 Billion LBO Loan Costs Tighten on Strong Demand - Bloomberg.com
What you need to know ahead of Hologic's earnings release - MSN
1 Healthcare Stock Worth Investigating and 2 That Underwhelm - Finviz
Hologic’s $8.5 billion LBO loan costs tighten on strong demandBloomberg News - TradingView — Track All Markets
Aug Macro: What are analysts price targets for Hologic IncEarnings Risk Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
Nordea Investment Management AB Increases Stake in Hologic, Inc. $HOLX - MarketBeat
Skin Rejuvenation Devices Market Set for Rapid Expansion - openPR.com
Professional Basketball Player Erica Wheeler and Hologic Team Up to Champion Cervical Cancer Screening - GuruFocus
Body Contouring Market Top Key Players 20262035: Allergan - openPR.com
How Recent Analyst Moves Are Rewriting The Story For Hologic (NasdaqGS:HOLX) - Yahoo Finance
Argus Research Downgrades Hologic (HOLX) to Hold | HOLX Stock Ne - GuruFocus
Hologic Inc Azioni (HOLX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
0.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):